Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Processa Pharmaceuticals Inc (NQ: PCSA ) 1.670 +0.009 (+0.53%) Streaming Delayed Price Updated: 3:37 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Processa Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 8 Next > Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results January 26, 2024 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling over 50 points on Friday The Dow traded up 0.05% to 38,069.66 while the NASDAQ fell 0.4% to 15,447.78. The S&P 500... Via Benzinga Topics Stocks Exposures US Equities InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Pricing Information for $7M Public Offering January 26, 2024 Via Investor Brand Network Exposures Product Safety 12 Health Care Stocks Moving In Friday's Intraday Session January 26, 2024 Via Benzinga Crude Oil Down 1%; American Express Shares Rise After Q4 Results January 26, 2024 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Friday. The Dow traded up 0.32% to 38,170.95 while the NASDAQ rose 0.10% to 15,525.24. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 26, 2024 Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter. Via Benzinga What's Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today? January 26, 2024 Processa Pharmaceuticals stock surge - 148.8% gain to $5.10 post Next Generation Capecitabine (NGC-Cap) Phase 1b success. Via Benzinga Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering January 26, 2024 From Processa Pharmaceuticals, Inc. Via GlobeNewswire Intel, Nvidia, AMD, Processa Pharmaceuticals, Tesla: Why These 5 Stocks Are On Investors' Radars Today January 25, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session January 25, 2024 Via Benzinga Nasdaq Edges Lower; American Airlines Posts Upbeat Earnings January 25, 2024 U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.25% to 37,900.45 while the NASDAQ fell 0.13% to 15,462.53. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities Why Is Processa Therapeutics (PCSA) Stock Up 90% Today? January 25, 2024 Processa Pharmaceuticals successfully completed its safety trial for a key cancer drug. Now, PCSA stock is soaring on the positive implications. Via InvestorPlace Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results January 25, 2024 U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday. The Dow traded up 0.06% to 37,829.32 while the NASDAQ rose 0.22% to 15,515.62. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 25, 2024 Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 25, 2024 Via Benzinga InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Completes Phase 1b Safety Evaluation of NGC-Cap January 25, 2024 Via Investor Brand Network Exposures Product Safety Why Processa Pharmaceuticals Stock Is Soaring January 25, 2024 Processa Pharmaceuticals shares are soaring Thursday after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Processa... Via Benzinga Exposures Product Safety Dow Surges Over 100 Points; US GDP Growth Tops Estimates January 25, 2024 U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.33% to 37,932.33 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 22, 2024 Shares of CommScope Holding Company, Inc. (NASDAQ: COMM) fell sharply during Monday’s session. B of A Securities analyst Tal Liani downgraded CommScope from Neutral to Underperform and lowered the... Via Benzinga US Stocks Higher; Nasdaq Jumps 100 Points January 22, 2024 U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities S&P 500 Gains 1%; State Street Reports Upbeat Earnings January 19, 2024 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.95% to 37,824.10 while the NASDAQ rose 1.39% to 15,264.30. The... Via Benzinga Topics Stocks Exposures US Equities Dow Jumps 150 Points; US Consumer Sentiment Surges In January January 19, 2024 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Friday. The Dow traded up 0.41% to 37,621.27 while the NASDAQ rose 0.66% to 15,154.43. The S&P... Via Benzinga Topics Stocks Exposures US Equities InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Plans to Expand NGC-Cap Program into Advanced or Metastatic Breast Cancer January 19, 2024 Via Investor Brand Network Exposures Product Safety Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 19, 2024 Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode... Via Benzinga Why Processa Pharmaceuticals (PCSA) Stock Is Skyrocketing January 19, 2024 Processa Pharmaceuticals shares are trading higher by 36.9% during Friday's session. The company announced plans to expand the development of Next Generation Capecitabine. Via Benzinga US Stocks Higher; Schlumberger Earnings Beat Estimates January 19, 2024 U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 50 points on Friday. Following the market opening Friday, the Dow traded up 0.18% to 37,536.76 while the NASDAQ rose... Via Benzinga Topics Earnings Stocks Exposures Financial US Equities Dow Surges Over 100 Points; M&T Bank Posts Weak Earnings January 18, 2024 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.35% to 37,398.50 while the NASDAQ rose 1.16% to 15,027.63.... Via Benzinga Topics Stocks Exposures US Equities Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 18, 2024 Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 18, 2024 Via Benzinga Crude Oil Rises Over 1%; Processa Pharmaceuticals Shares Slide January 18, 2024 U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 1% on Thursday. The Dow traded down 0.02% to 37,257.79 while the NASDAQ rose 1.19% to 15,032.26. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces 1-for-20 Reverse Stock Split January 18, 2024 Via Investor Brand Network Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.